Integrating TB, HIV Programs Will Lead To Efficiency In Life-Saving Treatments

The Center for Global Health Policy’s “Science Speaks” blog discusses findings of a “four-year South Africa study of co-infected patients [that] showed starting treatment for HIV during the course of anti-tuberculosis treatment, rather than waiting until TB treatment was completed, improved survival rates among those whose tuberculosis was responsive to first-line treatment.” Now, “[u]nder the funding model of the Global Fund to Fight AIDS, Tuberculosis and Malaria this year, countries with high TB-HIV co-infection rates will be required to submit joint TB-HIV concept notes which present integrated and joint programming for the two diseases…” (Aziz, 2/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.